http://www.fpnotebook.com/
Chronic Obstructive Pulmonary Disease
Aka: Chronic Obstructive Pulmonary Disease, Chronic Obstructive Lung Disease, COPD- See Also
- Epidemiology
- COPD Incidence in U.S.: 14-26 Million patients
- COPD affects 10% of adults in U.S.
- COPD fourth leading cause of death in U.S.
- Risk factors
- Cigarette smoking and Exposure to Tobacco smoke
- Active, continuous smoking confers COPD absolute risk of 25%
- Tobacco abuse is responsible for >80% of COPD cases
- Women have a greater degree of lung damage and Impairment for a given exposure
- Increased hyper-responsiveness to exogenous toxins
- Chapman (2004) Clin Chest Med 25:331-41
- Domestic or Occupational pollutants
- See Irritant-induced Asthma
- See Allergic Occupational Asthma
- Mineral Dust (e.g. Mining of coal or hard rock, Concrete manufacture, Silica)
- Organic Dust (e.g. Cotton, hemp, grains)
- Gas Fumes (e.g. heavy metals, welding, sulfur dioxide, isocyanates)
- Boschetto (2006) J Occup Med Toxicol 1:11
- Recurrent respiratory infections (especially Infancy)
- Atopic Patients
- Family History of COPD
- Alpha-1-Antitrypsin Deficiency
- Suspect in patients under age 45 without other risk
- Other protease deficiencies may also be related
- Cigarette smoking and Exposure to Tobacco smoke
- Definition: Chronic Obstructive Pulmonary Disease
- See Emphysema and Chronic Bronchitis
- Progressive chronic airflow obstruction
- Irreversibility distinguishes COPD from Asthma
- Types
- Diagnosis: Pulmonary Function Tests
- See Emphysema and Chronic Bronchitis
- GOLD criteria
- FEV1 to FVC ratio: <70% and
- FEV1 <80% of predicted post-Bronchodilator
- Severity stratification
- Moderate: FEV1 <80% of predicted
- Severe: FEV1 <50% of predicted
- Very Severe: FEV1 <30% of predicted
- Other findings
- DLCO diminished in Emphysema
- Increased Total Lung Capacity
- Increased Residual Volume
- Staging
- See COPD Staging
- Labs
- See Emphysema and Chronic Bronchitis
- Arterial Blood Gas
- Indicated in severe or very severe COPD
- Alpha-1-antitrypsin indications
- Age under 45 years
- No prior smoking history
- Family History of Alpha-1-Antitrypsin Deficiency
- Comorbid Cirrhosis
- Imaging: Chest XRay
- See Emphysema and Chronic Bronchitis
- Lung hyperinflation
- Diaphragm flattening
- Distal pulmonary vessel tapering
- Increased basilar markings in Chronic Bronchitis
- Differential Diagnosis
- Complications
- Severe Chronic Dyspnea (66%)
- Severe total body pain (25%)
- Screening
- Spirometry in 10 pack year smokers over age 40
- Grading
- Prognosis
- Factors associated with a worse prognosis (mortality)
- FEV1 < 750 cc (<50% of predicted)
- Rapid FEV1 decline
- Lower diffusion capacity
- Hypoxia with PaO2 <55 mmHg
- Older patients
- Continued Tobacco abuse
- Hypercapnia with PaCO2 > 45 mmHg
- Right-sided Heart Failure
- Malnutrition
- Resting Tachycardia
- Factors associated with a better prognosis
- Post-Bronchodilator FEV1 shows reversible component
- Atopy history
- Factors associated with a worse prognosis (mortality)
- References